Versant Vantage I, L.P. Insider Trading Activity

Average Profitability
24.58%
Insider Buys Quantity
2
Insider Buys Sum
$15M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Versant Vantage I, L.P.

Biography of Versant Vantage I, L.P.

No biography is available at this moment.

2019-10-07PurchaseAprea Therapeutics, Inc.
APRE
10 percent owner
333,333
1.2152%
$15.00$5M+53.58%
Total: 1
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.